Esperion Stock Surges 57% as ARCHIMED Acquires Company for $1.1 Billion
ARCHIMED will buy Esperion and take it private for $3.16/share (+58% premium) plus up to $100M extra payouts if targets are met.
ARCHIMED will buy Esperion and take it private for $3.16/share (+58% premium) plus up to $100M extra payouts if targets are met.
Morgan Stanley upgraded PSKY, sees $14 target (+37%). Likes WBD merger + AI upside, but risks remain from debt & execution.
Estée Lauder beat sales & profit, raised outlook, plans big job cuts and cost savings as beauty demand and online sales grow.
Moderna beat Q1 revenue on strong overseas COVID vaccine sales, revenue $389M, smaller US demand, reported a per-share loss.
Twilio grew fast in Q1: $1.41B revenue (+20%), higher profits, raised outlook; AI tools boost demand; stock jumped ~20%.
Atlassian stock jumps after strong results, driven by cloud growth, AI tools, and higher revenue outlook.